Corporate Board Profile
Tech Score: 8/100
2 mention(s) identify JEFF HIMAWAN, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. | 2016-04-25 | Dr. Himawan was a co-founder and Managing Director of Seed-One Ventures, LLC, a venture capital firm that specializes in the initial formation, financing and early operational development of technology-based companies, from 1996 to 2001. From 1983 to 1996, Dr. Himawan was a scientist in academic and industrial settings. He is the named inventor in several issued patents in the fields of wireless communication, biotechnology and protein chemistry. | Dr. Himawan has a Ph.D., was a scientist in academic and industrial settings, and is named inventor in several patents in wireless communication, biotechnology and protein chemistry, indicating technical expertise including programming or related skills. |
| GYRE THERAPEUTICS, INC. | 2018-05-11 | Dr. Himawan received his B.S. from Massachusetts Institute of Technology and his Ph.D. from Harvard University. He has over 20 years of experience as a scientist, entrepreneur and venture capitalist. | Dr. Himawan has a B.S. from MIT and a Ph.D. from Harvard University, with over 20 years of experience as a scientist and entrepreneur in technology-based companies, indicating strong technical and scientific background relevant to programming. |
| Filing Date | Source Excerpt |
|---|---|
| 2015-11-23 | Jeff Himawan, Ph.D., director, no software-related technical skills indicated. |
| 2016-04-25 | Dr. Himawan was a co-founder and Managing Director of Seed-One Ventures, LLC, a venture capital firm that specializes in the initial formation, financing and early operational development of technology-based companies, from 1996 to 2001. From 1983 to 1996, Dr. Himawan was a scientist in academic and industrial settings. He is the named inventor in several issued patents in the fields of wireless communication, biotechnology and protein chemistry. |
| 2017-01-12 | Jeff Himawan, Ph.D. |
| 2017-05-18 | Dr. Himawan received his B.S. from Massachusetts Institute of Technology and his Ph.D. from Harvard University. He has over 20 years of experience as a scientist, entrepreneur and venture capitalist. |
| 2018-05-11 | Dr. Himawan received his B.S. from Massachusetts Institute of Technology and his Ph.D. from Harvard University. He has over 20 years of experience as a scientist, entrepreneur and venture capitalist. |
| 2019-05-02 | Dr. Himawan is a Managing Director at Essex Woodlands Health Ventures and has over 20 years of experience as a scientist, entrepreneur, and venture capitalist in biotechnology. |
| Filing Date | Source Excerpt |
|---|---|
| 2006-04-13 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2006-09-08 | Jeff Himawan, Ph.D. |
| 2007-03-13 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2008-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2009-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2010-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. Based on his background in corporate finance and capital raising and his extensive experiences in the biotechnology industry, the Board believes Dr. Himawan has the appropriate set of skills to serve as a member of our Board. |
| 2011-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2012-04-30 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. Based on his background in corporate finance and capital raising and his extensive experiences in the biotechnology industry, the Board believes Dr. Himawan has the appropriate set of skills to serve as a member of our Board. |
| 2013-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2014-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2015-04-29 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2016-04-27 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2017-04-27 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2018-04-26 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. Based on his background in corporate finance and capital raising and his extensive experience in the biotechnology industry, the Board believes Dr. Himawan has the appropriate set of skills to serve as a member of our Board. |
| 2019-04-26 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2020-04-27 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2021-04-27 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
| 2022-04-26 | Jeff Himawan, Ph.D. has served on the board of directors of 12 different biotech/pharmaceutical companies (including four Nasdaq-listed companies) during the past 25 years. He holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. Based on his background in corporate finance and capital raising and his extensive experience in the biotechnology industry, the Board believes Dr. Himawan has the appropriate set of skills to serve as a member of our Board. |
| 2023-04-26 | Dr. Himawan holds a B.S. in biology from the Massachusetts Institute of Technology and a Ph.D. in biological chemistry and molecular pharmacology from Harvard University. |
Data sourced from SEC filings. Last updated: 2026-02-03